Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy-Reference-Cited by-同舟云学术

Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

Published:2017-12-14 Issue:5 Volume:23 Page:526-534
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Okumura Junya¹^ORCID,Shindo Yuichiro¹^ORCID,Takahashi Kunihiko²,Sano Masahiro¹,Sugino Yasuteru³,Yagi Tetsuya⁴,Taniguchi Hiroyuki⁵^ORCID,Saka Hideo⁶,Matsui Shigeyuki²,Hasegawa Yoshinori¹,

Affiliation:

1. Department of Respiratory Medicine; Nagoya University Graduate School of Medicine; Nagoya Japan

2. Department of Biostatistics; Nagoya University Graduate School of Medicine; Nagoya Japan

3. Department of Respiratory Medicine; Toyota Memorial Hospital; Toyota Japan

4. Department of Infectious Diseases; Nagoya University Hospital; Nagoya Japan

5. Department of Respiratory Medicine and Allergy; Tosei General Hospital; Seto Japan

6. Department of Respiratory Medicine; National Hospital Organization, Nagoya Medical Center; Nagoya Japan

Funder

Central Japan Lung Study Group (CJLSG)

National Center for Geriatrics and Gerontology

Research Funding for Longevity Sciences

JSPS KAKENHI

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13232/fullpdf

Reference41 articles.

1. World Health Organization http://www.who.int/mediacentre/factsheets/fs310/en/

2. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults;Mandell;Clin. Infect. Dis.,2007

3. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention;Niederman;Am. J. Respir. Crit. Care Med.,2001

4. Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis;Horita;Respirology,2016

5. Year in review 2016: respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology;Restrepo;Respirology,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiology;International Journal of Antimicrobial Agents;2023-10

2. Interventions to improve outcomes in community-acquired pneumonia;Expert Review of Anti-infective Therapy;2023-09-14

3. Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis;Critical Care;2023-05-31

4. Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: A targeted maximum likelihood estimation and survival analysis;2023-03-02

5. Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens;International Journal of Infectious Diseases;2022-11